Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II : April 2019-December 2026)
Not Applicable
Recruiting
- Conditions
- Cervical cancer and its precursor lesions
- Registration Number
- JPRN-UMIN000038883
- Lead Sponsor
- Showa University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 4000
Inclusion Criteria
Not provided
Exclusion Criteria
Individuals in either of the groups listed below will be excluded as subjects of the research 1. Female patients younger than 16 or older than 39 years 2. Female who do not have CIN, AIS or cervical cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of HPV16/18 positives among subjects of cervical cancer, CIN2/3 and AIS in women aged 16-24, and 25-29 years
- Secondary Outcome Measures
Name Time Method 1. The number of women aged 16-24, and 25-29 years who contract cervical cancer,CIN2/3, AIS 2. The proportion of HPV16/18 positives among subjects of CIN1 in women aged 16-24, and 25-29 years 3. The proportion of HPV16/18 positives among subjects of cervical cancer, CIN2/3 and AIS in women aged 16-39 years 4. The distribution of HPV types among subjects of cervical cancer, CIN1/2/3, and AIS in women aged 16-39 years 5. The number of women aged 16-39 years who contract cervical cancer, CIN2/3, and AIS 6. The proportion of HPV16/18 positives among women aged 16-39 years with CIN1 7. The number of deaths from cervical cancer among women aged 16-39 years